Automatic Hybrid Insulin Delivery Systems Help Manage T1D Automatic Hybrid Insulin Delivery Systems Help Manage T1D
A prospective evaluation by 16 diabetes specialists in Spain suggests that advanced hybrid closed-loop systems improve glycemic control in patients with type 1 diabetes.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 12, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
So Far, No Ties Between GLP-1s and Suicidal Thoughts So Far, No Ties Between GLP-1s and Suicidal Thoughts
Preliminary FDA investigation finds no evidence of association between the drug class and suicidal thoughts or actions.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 11, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Strict Glycemic Control for Renal Benefit May Come With Risk Strict Glycemic Control for Renal Benefit May Come With Risk
A new study explores if the kidney failure risk equation can identify patients with type 2 diabetes who would show renal improvement with intensive glycemic management.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 11, 2024 Category: Endocrinology Tags: Nephrology Source Type: news
Weight Loss Drug Windfall Attracts Pharma Companies Weight Loss Drug Windfall Attracts Pharma Companies
Pharmaceutical executives from Amgen to Pfizer are plotting to break into the lucrative obesity market by developing or cutting deals to acquire better drugs that will...Reuters Health Information (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 11, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Vertex Pauses Islet Cell Study After Patient Deaths Vertex Pauses Islet Cell Study After Patient Deaths
The deaths are unrelated to the investigational allogeneic stem cell –derived product VX-880, the company says.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 10, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Combined Icodec + Semaglutide Looks Good vs Insulin Combined Icodec + Semaglutide Looks Good vs Insulin
Fixed-ratio once-weekly insulin icodec plus semaglutide product IcoSema was noninferior to daily glargine + aspart.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 10, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Combined Icodec + Semaglutide Looks Good Compared to Insulin Combined Icodec + Semaglutide Looks Good Compared to Insulin
Fixed-ratio once-weekly insulin icodec plus semaglutide product IcoSema was noninferior to daily glargine + aspart.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 10, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Food an Effective Medicine in Diabetes? Food an Effective Medicine in Diabetes?
New findings challenge the growing popularity of food-as-medicine programs by showing that one such program didn ' t improve glycemic control in individuals with high blood sugar.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 10, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Does Telemedicine in Obesity Care Reduce Weight Bias? Does Telemedicine in Obesity Care Reduce Weight Bias?
Dr Zoobia Chaudhry explores aspects of telemedicine in obesity care and its potential to reduce weight bias in several ways, highlighting how its effectiveness can vary, based on multiple factors.Medscape Diabetes & Endocrinology (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 9, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Article Source Type: news
Pfizer to Remain Aggressive on Obesity Market After Setback Pfizer to Remain Aggressive on Obesity Market After Setback
Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to...Reuters Health Information (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 8, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Lilly CEO Says Weight-loss Drug Zepbound Weekly Prescriptions Hit 25,000 in December Lilly CEO Says Weight-loss Drug Zepbound Weekly Prescriptions Hit 25,000 in December
Eli Lilly CEO David Ricks on Monday said the company ' s powerful weight-loss drug Zepbound hit 25,000 new prescriptions per week at the end of December and that its 2024...Reuters Health Information (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 8, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
New Tool May Offer Diagnostic Edge for Diabetic Neuropathy New Tool May Offer Diagnostic Edge for Diabetic Neuropathy
Researchers adapted optical diffusion technology in a low-cost portable device to assess microvascular blood flow in human skin and showed proof of concept in early detection of diabetic neuropathy.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 8, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
SGLT2 Inhibitors Begin to Show Potential in Rheumatology SGLT2 Inhibitors Begin to Show Potential in Rheumatology
Sodium-glucose cotransporter-2 inhibitors are not approved to treat gout, lupus, or lupus nephritis, but clinicians are uncovering signs of benefits in these conditions.MDedge News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 8, 2024 Category: Endocrinology Tags: Rheumatology Source Type: news
Wegovy, Ozempic Not Linked to Increase in Suicidal Thoughts, US Study Finds Wegovy, Ozempic Not Linked to Increase in Suicidal Thoughts, US Study Finds
A large U.S. study found no evidence that taking Novo Nordisk ' s Ozempic or Wegovy is tied to an increase in suicidal thoughts, researchers reported on Friday.Reuters Health Information (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 5, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Lilly Launches Website, Home Delivery Option for Weight-loss Drug Lilly Launches Website, Home Delivery Option for Weight-loss Drug
Eli Lilly and Co on Thursday launched a website to enable people to directly order from the drugmaker including its weight-loss medicine Zepbound as well as connect people...Reuters Health Information (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 4, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
